BriaCell Therapeutics Corp.

TSX:BCT.TO

Biotechnology

Healthcare
$5.75 +18.88%

+$0.94 today

Market cap
$50.02M
Beta
1.53
P/E (TTM)
-0.3
EPS (TTM)
-$4.23
52W Low $3.68High $20.40

Volume 0.00M

Average 0.01M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$27.54M

FY 2025 · Annual

Net Income

-$26.63M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Jul 2021
FY2022
Jul 2022
FY2023
Jul 2023
FY2024
Jul 2024
FY2025
Jul 2025
Revenue00000
Cost of Revenue15.55K000107.93K
Gross Profit(15.55K)000(107.93K)
Gross Margin—————
Research & Development2.02M8.02M15.34M27.18M21.53M
Selling, General & Admin4.96M7.27M7.94M6.15M5.9M
Operating Expenses6.97M15.29M23.27M33.33M27.43M
Depreciation & Amortization15.55K15.27K15.27K83.9K107.93K
EBITDA(7.1M)(26.82M)(23.26M)(4.85M)(27.43M)
EBITDA Margin—————
Operating Income(7.11M)(15.29M)(23.27M)(33.33M)(27.54M)
Operating Margin—————
Interest Income3.21K136.73K891.21K288.02K121.42K
Interest Expense80.09K9790037.43K
Other Income / Expenses(6.84M)(11.55M)2.97M28.4M656.6K
Income Before Tax(13.82M)(26.84M)(20.3M)(4.93M)(26.88M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(13.82M)(26.84M)(20.3M)(4.79M)(26.63M)
Net Margin—————
EPS (Basic)(467.51)(259.50)(195.00)(43.68)(62.95)
EPS (Diluted)(467.51)(259.50)(195.00)(43.68)(62.95)
Weighted Avg Shares30.13K103.29K104.13K109.7K423.11K
Weighted Avg Shares (Diluted)30.13K103.29K104.13K109.7K423.11K

BCT.TO Earnings Waterfall · TTM

TSX:BCT.TO · Revenue to Net Income

Key Ratios

EPS$-12.20
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-0.9
P/S Ratio0.0

Analysis

$0 of revenue converted into -$30.7M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-12.20, tying the income statement back to per-share earnings.

Competitors

Peer companies in the same sector

Health

No competitor data available.

Recent Filings

Recent regulatory filings

No filings found.

How much revenue does BCT.TO generate?

BriaCell Therapeutics Corp. (BCT.TO) reported $0.00 of revenue in fiscal 2025.

Is BCT.TO profitable?

BriaCell Therapeutics Corp. (BCT.TO) reported -$26.63M of net income.